Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study - Gadgeel, S; Peters, S; Mok, T (Ann Oncol, 2018)